Aquestive Therapeutics, Inc. (AQST) stock
AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.70−0.06 (-1.60%)
Close on Nov 17, 2026Market cap $464.39MP/E –Yield –
Aquestive Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Aquestive Therapeutics's EV/EBITDA was 20.2× on Jan 31, 2019.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Jan 31, 2019 | 20.2× | −1.0 |
| 2018 | Dec 31, 2018 | 21.1× | – |
See a number that looks wrong?